Please provide your email address to receive an email when new articles are posted on . CVS Caremark, one of the nation’s largest pharmacy benefit managers, will remove Humira from its major national ...
Meitheal, a biopharmaceutical company focused on developing and commercializing generic injectables, fertility, biologic and branded products, has gained exclusive U.S. commercial rights to Yusimry, a ...
As AbbVie gears up for Humira's loss of exclusivity next year, investors are keeping a close eye on its successor immunology franchises. In the first quarter, one key med failed to live up to analyst ...
April 26 (Reuters) - AbbVie (ABBV.N), opens new tab expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen after recent changes by U.S. pharmacy benefit managers and as ...
(Bloomberg)—Amgen Inc. is challenging one of the world’s best-selling medications with an unusual strategy: charging two list prices for the same medicine. The company on Tuesday launched Amjevita, ...
SPRINGFIELD, Mass. (WWLP) – Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of ...
July 18 (Reuters) - A close copy version of Abbvie's (ABBV.N), opens new tab blockbuster arthritis drug Humira will be available at a 92% discount to its list price on the GoodRx website, the digital ...
Analyst Evan Seigerman from BMO Capital assigned a Buy rating on AbbVie (ABBV – Research Report) and keeping the price target at $214.00. Evan Seigerman has given his Buy rating due to a combination ...
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will draw on a bit of ...
Zacks Investment Research on MSN
Here's How ALVO's Commercial Partnerships Are Driving Top-line Growth
Biosimilar drugmaker Alvotech ALVO has positioned itself differently from other players in the space by using partnerships as ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In 2021, Humira — the blockbuster ...
Amgen is introducing Amjevita (adalimumab-atto), a biosimilar to AbbVie’s Humira. Amjevita was the first biosimilar to Humira approved by the Food and Drug Administration in 2016. "With today's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback